Alcohol and Other Drug Abuse (AODA) Practice Exam

Luminal, which is primarily used as an anticonvulsant medication, is not commonly associated with the treatment of opioid abuse. The main purpose of Luminal is to manage seizure disorders. It does not have the properties that would effectively address the physiological or psychological aspects of opioid addiction or withdrawal.

In contrast, methadone, buprenorphine, and levo-alpha acetyl methadol are specifically designed and commonly employed in the management of opioid use disorder. Methadone is a long-acting opioid agonist that helps in reducing withdrawal symptoms and cravings, thereby stabilizing individuals in recovery. Buprenorphine, a partial opioid agonist, also aids in alleviating withdrawal symptoms but with a lower risk of overdose compared to full agonists. Levo-alpha acetyl methadol is another long-acting medication that functions similarly to help manage opioid dependence. These medications are integral to medication-assisted treatment (MAT) protocols used to support individuals in overcoming opioid addiction.